The Pandemic as a Catalyst for Disruptive Innovation in Clinical Pharmacology.

Giacomini, Kathleen M; van der Graaf, Piet H

Giacomini, Kathleen M; van der Graaf, Piet H.

Giacomini KM; University of California San Francisco, San Francisco, California, USA.
van der Graaf PH; Certara, Sheffield, UK.

Clin Pharmacol Ther ; 111(3): 529-532, 2022 03.

Article in English | MEDLINE | ID: covidwho-1712060

Subject(s)

Pandemics/prevention & control; Pharmacology, Clinical/methods; COVID-19/immunology; COVID-19/prevention & control; Delivery of Health Care/methods; Humans; Organizational Innovation; Small Molecule Libraries/therapeutic use; Vaccines/immunology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pharmacology, Clinical / Pandemics Type of study: Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Clin Pharmacol Ther Year: 2022 Document Type: Article Affiliation country: Cpt.2519

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google